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Feline diabetes mellitus (DM) is strikingly similar to human type 2 diabetes. Cats and 
humans share many risk factors for the disease, including an association with insulin 
resistance coupled to obesity and a sedentary lifestyle. There are also pathophysiological 
resemblances, with β-cell loss and amyloid deposition in the islets of Langerhans in the 
pancreas. In people, ethnicity has been associated with an increased risk of DM, and in 
cats, a breed predisposition has been identified, with the Burmese breed at increased risk. 
The aims of this thesis were to identify risk factors for DM in cats and to increase under-
standing of disease pathogenesis.  
We used insurance data from Agria Pet Insurance to determine the general incidence 
of DM in Swedish cats, and the incidence in relation to age, sex and breed. We found that 
incidence rates peaked when cats were 13 years old. Male cats developed DM twice as 
often as female cats. The Burmese breed, along with the Russian Blue, Abyssinian, and 
Norwegian Forest cat breeds, showed an increased risk of DM, while several breeds 
showed a lower risk. Owners of diabetic and non-diabetic cats from the same cohort were 
invited to participate in a web survey, with questions on e.g. type of diet, feeding regime, 
and activity levels. We found associations between overweight and an increased risk of 
DM. Access to the outdoors was protective. There was an increased risk of DM in cats 
eating predominantly dry food, compared to wet food, in the group of cats considered 
normal-weight by their owners. Since overweight was shown to be a strong risk factor 
for DM, we studied if factors associated with DM were also associated with risk of 
overweight. Several shared risk factors for DM and overweight were found, such as eating 
predominantly dry food, being male, and considered being a greedy eater. Cats from 
Birman and Persian breeds, with a decreased risk of DM, were less often overweight. 
Finally, we studied the metabolism in the Burmese, Birman, and Maine coon breeds, 
using nuclear magnetic resonance (NMR) spectroscopy and hormone immunoassays. 
There were differences in the metabolic profiles between breeds, with patterns of metabo-
lites in the Burmese cats resembling patterns seen with insulin resistance in people.  
In conclusion, both new and previously reported factors associated with DM and 
overweight in cats were identified in this thesis. Knowledge of predisposing factors can 
help owners and veterinarians to identify cats at risk, and enables prevention of disease.   
Keywords: Burmese, cat, dry food, epidemiology, Felis catus, lifestyle, metabolomics, 
overweight, obesity, type 2 diabetes.  
Author’s address: Malin Öhlund, SLU, Department of Clinical Sciences,  
P.O. Box 7054, 750 07 Uppsala, Sweden. E-mail: Malin.Ohlund@slu.se 
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Abstract 
 
 
Diabetes mellitus (DM) är en endokrin sjukdom hos katt, som är slående lik typ 2 diabetes 
hos människa. Katter och människor delar många riskfaktorer för sjukdomen, inklusive 
ett samband med insulinresistens kopplat till övervikt och en stillasittande livsstil. Det 
finns också patofysiologiska likheter, med förlust av β-celler och inlagring av amyloid i 
Langerhans öar i bukspottkörteln. En raspredisposition har setts hos katt, med en förhöjd 
risk för rasen burma, vilket liknar situationen hos människa där etnicitet har visat sig ha 
ett samband med en ökad risk för DM. Övergripande syften med avhandlingen var att 
identifiera riskfaktorer för DM hos katt och öka förståelsen för sjukdomens uppkomst. 
Vi använde försäkringsdata från Agria djurförsäkring för att fastställa den generella 
incidensen av DM hos svenska katter, samt incidensen i relation till ålder, kön och ras. Vi 
fann att incidensen var som högst för katter vid 13 års ålder. Hankatter drabbades av DM 
dubbelt så ofta som honkatter. Burma, tillsammans med raserna russian blue, abessinier 
och norsk skogkatt, visade en ökad risk för DM, medan flera andra raser istället visade en 
minskad risk. Vi bjöd in ägare till katter med och utan DM att delta i en enkät-
undersökning, med frågor om bland annat fodertyp, utfodring och aktivitetsnivå. Vi fann 
ett samband mellan övervikt och en ökad risk för DM. Tillgång till utevistelse skyddade 
däremot mot DM. I gruppen katter som bedömts som normalviktiga av sina ägare 
påvisades en ökad risk för DM hos katter som åt mestadels torrfoder jämfört med katter 
som åt mestadels blötmat. Eftersom övervikt visade sig vara en stark riskfaktor för DM 
undersökte vi om faktorer som visat samband med DM också hade ett samband med 
övervikt. Vi fann flera gemensamma riskfaktorer för DM och övervikt, som att äta 
mestadels torrfoder, vara av hankön, och att vara glupsk. Raserna birma och perser, med 
en nedsatt risk för DM, var mindre ofta överviktiga. Slutligen studerade vi metabolismen 
hos katter av raserna burma, birma och maine coon med NMR-spektroskopi och 
hormonanalyser. Den metabola profilen skilde mellan raserna, med ett mönster av 
metaboliter hos burmorna som liknar det som ses hos människor med insulinresistens. 
Sammanfattningsvis har både nya och tidigare kända riskfaktorer för DM och övervikt 
hos katt identifierats i avhandlingen. Kunskap om predisponerande faktorer kan hjälpa 
ägare och veterinärer att identifiera katter med en förhöjd risk, och ge möjlighet att 
förebygga sjukdom. 
Nyckelord: Burma, epidemiologi, Felis catus, fetma, livsstil, metabolomik, torrfoder, typ 
2-diabetes, övervikt.  
Författarens adress: Malin Öhlund, SLU, Institutionen för kliniska vetenskaper,  
Box 7054, 750 07 Uppsala. E-post: Malin.Ohlund@slu.se  
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Diabetes mellitus (DM) is a disease with a worldwide increasing prevalence in 
people, as a consequence of the obesity epidemic encountered in many parts of 
the world (Chan et al., 2009; Chen et al., 2012). In 2015, the International 
Diabetes Federation estimated that more than 452 million people suffered from 
DM, and it was postulated that by 2040, one in ten adults will have developed 
DM. Diabetes mellitus is considered to be a disease with an increasing prevalence 
also in domestic cats (Prahl et al., 2007).  
There are several types of DM in people, of which type 1 and type 2 are the 
most prevalent. Type 1 DM (T1DM) is generally thought to be caused by an 
immune-associated destruction of insulin-producing pancreatic β-cells, leading 
to absolute insulin deficiency (Atkinson et al., 2014). Type 2 DM (T2DM) on the 
other hand, is characterised by a relative insulin deficiency caused by pancreatic 
β-cell dysfunction coupled with insulin resistance in target organs such as 
muscle and adipose tissue (Chatterjee et al., 2017). Type 2 DM is by far the most 
common type of DM in people, accounting for approximately 90% of all cases 
(Chen et al., 2012).  
Diabetic cats most frequently suffer from a type of DM strikingly similar to 
T2DM in people (Rand, 1999; O'Brien, 2002). In fact, cats are the only known 
non-primate species to develop spontaneous DM that is similar to human T2DM 
(Verkest & Bjornvad, 2012). Cats and people also share risk factors for DM, such 
as obesity and a sedentary lifestyle, and have similar pathophysiological changes 
within the pancreas, with β-cell loss and amyloid deposition (Rand et al., 2004; 
Osto et al., 2013). Naturally occurring amyloid deposition is a feature so far only 
encountered in cats and primates, and not in other animals (Osto & Lutz, 2015).  
Obesity is a major risk factor for DM in cats and people, and the risk factors 
for DM are similar to the risk factors for obesity. Therefore, risk factors for both 
DM and obesity will be acknowledged and discussed in this thesis.  
1 Introduction 
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1.1 History 
1.1.1 Diabetes mellitus in people 
Diabetes mellitus was described as a disease in humans with “too great emptying 
of the urine” already in 1500 BC in Egypt. The first described cases were most 
likely to have suffered from T1DM. Diabetes as a term has been recognised from 
around 250 BC in Greece. Diabetes means “to pass through”, and refers to the 
increased urination encountered in diabetic patients. The term mellitus means 
“from honey” and was added by Thomas Willis in the 17th century to describe 
the sweetness of the urine, and to distinguish DM from diabetes insipidus, 
another disease  with similar clinical signs, but related to the hormone vaso-
pressin (antidiuretic hormone) and unrelated to DM (Zajac et al., 2010; 
Karamanou et al., 2016). However, the observation that urine from diabetic 
patients attracts flies was noted by physicians in India, already at around 1500 
BC. The separation of the diabetic patients into two groups; today’s type 1 and 2 
DM, was observed by Indian physicians Sushruta and Charaka in the fifth century 
AD, who associated the disease with youth and obesity, respectively (Zajac et al., 
2010).  
The prognosis for the disease was grave for over three millennia, with an 
invariably fatal outcome. Aretaeus of Cappadocia, a Greek physicist, wrote in 
the second century AD (Zajac et al., 2010): 
 
Diabetes is a dreadful affliction, not very frequent among men, being a melting 
down of the flesh and limbs into urine. The patients never stop making water and 
the flow is incessant, like the opening of the aqueducts. Life is short, unpleasant 
and painful, thirst unquenchable, drinking excessive and disproportionate to the 
large quantity of urine, for yet more urine is passed. . . . If for a while they abstain 
from drinking, their mouths become parched and their bodies dry; the viscera 
seem scorched up, the patients are affected by nausea, restlessness and a burning 
thirst, and within a short time they expire. 
 
Before the discovery of insulin by Banting and colleagues in the 20th century 
(Banting & Best, 1922; Banting et al., 1923; Banting et al., 1991), DM was 
mainly treated with different sorts of diets. John Rollo, a surgeon general in the 
British army, developed a low-carbohydrate diet for patients with DM (Anderson, 
1965). Others, like the leading American diabetologist of the time Frederick 
Allen, suggested that limiting of food supply would improve the disease.  
Other significant scientific advances preceded the discovery of insulin. In 
1869, the German pathologist Paul Langerhans described the tiny islets of 
pancreatic tissue that were later suggested by the French scientist Gustave-
17 
 
Edouard Laguesse to be the source of a substance involved in blood glucose 
control. The Belgian physician Jean de Mayer named this substance “insulin” in 
1909 (Zajac et al., 2010).  
In 1922, Frederick Grant Banting and his student Charles Best (Figure 1), 
treated the first human DM patient, a 14-year old boy, with a pancreatic extract, 
after first successfully treating a pancreat-
ectomised diabetic dog with the same 
substance. The pancreatic duct in dogs was 
ligated, causing the pancreas to atrophy, 
after which the degenerated pancreas with 
the remaining islets was harvested, in order 
to produce the extract (Banting et al., 1922). 
As a result of this treatment, the boy 
survived an additional 13 years. Another 
boy, one of the first to receive insulin 
treatment in 1922, survived for more than 
70 years with insulin therapy. Banting was 
awarded the Nobel Prize in October 1923, 
together with John J.R. MacLeod, a 
professor at the University of Toronto 
where Banting performed his experiments. 
Throughout the 20th century, DM was 
classified based on clinical manifestations 
as juvenile or adult. In 1979, diabetic 
patients were classified mainly into two 
groups by the International Diabetes Data Group. The insulin-dependent type of 
DM (IDDM), was considered a distinct subclass, as was the noninsulin-dependent 
type (NIDDM). At the end of the century, this terminology was slowly replaced 
by type 1 and 2 DM, and the terms IDDM and NIDDM were abandoned (Gilor et 
al., 2016a). 
1.1.2 Diabetes mellitus in cats 
When searching for “diabetes AND cat” in biomedical databases such as 
PubMed, Scopus, and Web of Science; only reports of experimentally induced 
DM in cats are encountered prior to the 1950’s (Homans, 1914; Long & Lukens, 
1936; Dohan & Lukens, 1947). A suspected case of DM in a laboratory cat is 
briefly mentioned in a footnote in a paper from 1916 (Mettam & Craig, 1916). 
In a report on nine cases of DM (eight dogs and one cat) from 1951, the authors 
describe a spontaneous case of DM in a Persian cat (Schlotthauer & Millar, 1951). 
Figure 1. Sir Frederick Banting (right) 
and Dr Charles Best, co-discoverers of 
insulin, with the dog Marjory 
(depancreatised and treated with insulin), 
1921. Wellcome Library, London. 
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It appears that the earliest reports of feline DM concerned cases with concurrent 
pancreatic disease, such as a large adenoma replacing the pancreatic tissue, or 
chronic pancreatitis (Bloom 1937; Holzworth & Coffin, 1953), and not the 
obesity-related disease most often encountered today.  
Joan Joshua described the disease in cats in a review from 1963, stating that 
most of the cases seen were aged neutered male cats, and that according to her 
experience, DM was not necessarily associated with obesity (Joshua, 1963). 
Contrary to today’s situation, in 1986, DM in cats was still considered to be 
less common than in dogs (Stogdale, 1986; Rios & Ward, 2008a). The 
association of DM in cats with advancing age and obesity was starting to be 
noticed, but in the 1990’s, cats were still mainly classified as having IDDM, 
although scientists commented on the fact that the cats’ insulin secretion in 
response to glucose tolerance testing rather suggested resemblance with NIDDM 
(Nelson & Lewis, 1990; Wallace & Kirk, 1990). Others however, started using 
the T2DM classification we use today at this time point (Wolfsheimer, 1990; Lutz 
& Rand, 1993; Lutz & Rand, 1995). 
1.1.3 Overweight and obesity in people and cats 
Chronic food shortage and malnutrition have been a 
curse for mankind from the dawn of history. During 
prehistoric times, natural selection rewarded a 
“thrifty” genotype, where an ability to store fat was 
beneficial for survival. In times of nutrient shortage; 
excess weight has also been a symbol of wealth, 
represented here by the figurine Venus of 
Willendorf (Figure 2), an icon of fertility from 
25,000 BC.  
The current worldwide epidemic of obesity, 
now recognised as a public health crisis is however 
just a few decades old. Only after the technological 
advances of the 19th century did food supply 
gradually increase in the industrialised world. The 
initial effects on public health were beneficial, with 
increased longevity and body size (Eknoyan, 2006).  
However, the overabundance of food coupled with 
reduced physical activity, has resulted in the dramatic 
increase in overweight and obesity seen in the last 
decades. Overweight and obesity are today important 
health problems and considered a growing global 
Figure 2. The Venus 
of Willendorf, by user 
Matthias Kabel, CC-
BY-SA-3.0, via 
Wikimedia Commons. 
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epidemic, in both people and animals (Kopelman, 2000; Flegal et al., 2002; 
Eknoyan, 2006; German, 2006).  
The prevalence of obesity among US adults increased from 13% in the early 
1960’s, to 31% at the turn of the millennium. Most investigators agree that the 
prevalence of obesity is also increasing in cats. In a report from 1974, the preva-
lence of obesity in cats was only 6–12 % (Anderson, 1973). Later reports have 
shown higher prevalences, up to 63% in some cat populations (Cave et al., 
2012). 
In people, one way to classify overweight or obesity in adults is by 
calculating the body mass index (BMI). The BMI is defined as the weight in 
kilograms divided by the square of the height in meters (kg/m2). Overweight is 
defined as having a BMI greater than or equal to 25 kg/m2 and below 30 kg/m2, 
and obesity occurs when the BMI is greater than or equal to 30 kg/m2 (Guh et al., 
2009). The BMI measurement however, does not discriminate between excess 
body fat and increased muscle mass. Other techniques, all with their own short-
comings, such as dual energy X-ray absorptiometry (DEXA) (Prentice & Jebb, 
2001), bioelectrical impedance (Meeuwsen et al., 2010), and skin-fold thickness 
(Freedman et al., 2009) measurements can also be used.  
In cats, obesity can be assessed subjectively, for example using a body 
condition score (BCS) system, or objectively using DEXA or magnetic resonance 
imaging (Laflamme, 1997; Hoenig, 2012). In clinical practice, the objective 
ways to evaluate body condition in cats are not usually performed for practical 
reasons. The BMI system has also been used in cats and can be calculated 
according to the following formula, but it has not gained wide acceptance in 
general veterinary practice or research (Bjornvad et al., 2011; Nelson et al., 
1990; Hoenig, 2012):  
 
BMI = body weight (kg) / [body length (m) × height (m)] 
 
The 5- or 9-grade scale BCS systems provide a semi-quantitative assessment of 
the cat’s body condition that is easy to use in a clinical setting, and the systems 
have been validated and shown to be repeatable both within and between scorers 
(Laflamme, 1997; German et al., 2006; Baldwin et al., 2010). 
1.2 Obesity and diabetes mellitus in cats and people 
today  
In 2014, more than 1.9 billion adults were overweight, and more than half a 
billion were obese, according to the World Health Organization (WHO) (Figure 
3).  
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     no data      < 5%      5–10%      10–15%      15–20%    
     20–25%      25–30%       30–35%         35–40%        40–45%    
     45–50%         50–55%          > 55%  
Figure 3. Map of obesity prevalence in adult females (% with a BMI ≥ 30) per country (2016). Data 
from WHO, map by user Lukepryke (own work), CC BY-SA 4.0, via Wikimedia Commons.  
The prevalence of obesity has more than doubled since 1980, and at least 2.8 
million people each year die as a result of being overweight or obese. About 422 
million people today suffer from DM, and the prevalence has been steadily 
increasing during the last decades, mirroring the increasing prevalence of over-
weight and obesity. In 2012, DM was the direct cause of 1.5 million deaths. 
Today, similar to the situation in humans, 80–95% of all diabetic cats are 
believed to suffer from T2DM associated with insulin resistance, with obesity as 
the most prominent risk factor (Rand et al., 2004; Chen et al., 2012). The 
prevalence of overweight and obesity among cats today differs between 
populations, but recent reports from countries like the United States, United 
Kingdom, the Netherlands, and New Zeeland show that between one and two 
thirds of included cats were either overweight or obese (Lund et al., 2005; 
Courcier et al., 2010; Cave et al., 2012; Corbee, 2014). The prevalence and 
incidence of feline DM is more difficult to measure. The prevalence will differ 
depending on the population examined. For example, the prevalence of DM in a 
cohort of insured cats in the United Kingdom was found to be 1 in 230 cats, or 
0.43% (McCann et al., 2007). Others have reported animal hospital prevalence 
or clinical laboratory prevalence from 1 in 179 (0.6%) to 1 in 98 cats (1.0%) 
(Rand et al., 1997; Baral et al., 2003). The current prevalence and incidence of 
feline DM are unknown. 
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1.3 Measuring disease frequency  
1.3.1 Prevalence and incidence 
When describing how often a disease or another trait occurs in a population, 
different measures can be used. Prevalence describes the number of existing 
cases, and is affected by a number of mechanisms, for example length of disease 
time (Jager et al., 2007). If the disease investigated is lethal and untreatable, like 
DM before the discovery of insulin, few prevalent cases will exist because of the 
short lifespan. On the other hand, if an effective treatment is discovered and 
used, patients will survive, and the number of prevalent cases will therefore 
increase. The incidence, another measure of disease occurrence, can however 
remain unaffected. Incidence, in contrast to prevalence, measures the number of 
new cases arising in a population over a given period of time. The difference 
between prevalence and incidence can thus be summarised as “how many 
individuals have this disease right now?” and “how many individuals per year 
acquire this disease?”, respectively (Rothman, 2012). A schematic drawing of 
the concepts incidence and prevalence is shown in Figure 4. 
 
Figure 4. Schematic drawing of the concepts incidence and prevalence, with incidence as “all new 
cases” and prevalence as “all existing cases”, where prevalence is affected by both disease length 
and survival. 
Incidence
Prevalence
Deaths/cures
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To assess incidence, the population at risk needs to be known. Incidence is 
often expressed as the incidence rate (IR), which is the number of new cases 
divided by the person-time at risk. When calculating the IR, each individual at 
risk of contracting the disease contributes with person-time at risk. Incidence is 
usually more useful than prevalence in understanding the disease aetiology. If 
the incidence increases in a population, there is probably an emerging new risk 
factor that promotes the disease. Prevalence is more important as a measure of 
the burden of the disease on society, with no regard to time at risk or when 
individuals may have been exposed to a possible risk factor (Rothman, 2012). 
Studies on DM and obesity frequency in cats have mainly been reporting 
prevalence (Panciera et al., 1990; Sloth, 1992; Scarlett et al., 1994; Rand et al., 
1997; McCann et al., 2007; Prahl et al., 2007; Colliard et al., 2009; Lederer et 
al., 2009; Courcier et al., 2010; Cave et al., 2012; Sallander et al., 2012). The 
reason for this is probably a lack of information on the population at risk which 
is necessary to estimate the incidence. It has been generally accepted that the 
prevalence of overweight, obesity, and DM have increased during the last 
decades, even though there are relatively few studies supporting this allegation. 
Therefore, more studies are needed, and especially studies on incidence would 
be beneficial. 
1.4 Risk factors for overweight, obesity, and diabetes 
mellitus 
The exact aetiology of T2DM is unknown in both people and cats. The disease is 
characterised by a combination of an insulin secretory defect and insulin 
resistance (Kahn, 2003; Scott-Moncrieff, 2010). Insulin resistance is a condition 
where cells in the body fail to respond normally to the hormone insulin. Insulin 
resistance is an important component of the pathogenesis of T2DM in both people 
and cats. With insulin resistance, if the pancreatic β-cells are unable to produce 
sufficient amounts of insulin to maintain normal blood sugar levels; DM develops 
(Shulman, 2000; Kahn, 2003; Scott-Moncrieff, 2010). A number of factors 
associated with an increased risk of overweight, obesity and DM have been 
identified in both people and cats. 
In epidemiology, a risk factor is defined as a variable associated with an 
increased risk of disease. Risk factors are not necessarily causal, because 
association or correlation does not prove causation which is important to bear in 
mind when interpreting results from such studies. The concepts of bias and 
confounding are also important to recognise when carrying out epidemiological 
studies, as they can influence the results.  Bias in an epidemiological study may 
be defined as any systematic error that results in an incorrect estimate of the 
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association between exposure and risk of disease. Bias can for example result 
from a non-representative sampling of a population, or relate to facts such as a 
tendency to more easily remember events preceding a disease occurrence, e.g. a 
recall bias. For example, owners of diabetic cats may search their memories 
more thoroughly than owners of unaffected control cats to try to recall exposure 
to factors that they believe might be associated with the disease. Confounding 
on the other hand, occurs when the effects of two associated exposures or factors 
have not been identified and separated, and can result in the interpretation that 
the effect is due to one variable rather than the other. A classic example is the 
strong association seen between ice cream sales and the number of shark attacks. 
The confounding variable here is temperature. Warmer temperatures cause ice 
cream sales to go up, and also bring more people to the beach, increasing the risk 
of shark attacks. 
Risk factors for a disease can be categorised as either modifiable or non-
modifiable. Type of diet and activity level represent modifiable, or environ-
mental, factors. Non-modifiable factors cannot be changed in the individual, and 
include factors such as age, ethnicity, and genetic susceptibility. They are also 
referred to as demographic factors. The word demography originates from the 
Greek words dêmos, “the people”, and graphô, meaning “description of”. Both 
modifiable and non-modifiable risk factors contribute to an increased risk for 
DM in people, as well as in cats, although the genetic predisposition to DM in cats 
is still unexplored. In people, most of the identified genetic risk loci are related 
to β-cell dysfunction rather than to insulin resistance or obesity (Florez, 2008; 
Dupuis et al., 2010; Herder & Roden, 2011). However, in both cats and people, 
overweight and obesity are the most important predictors of T2DM (Panciera et 
al., 1990; Chen et al., 2012).  
Another aspect to consider is the relationship between time points of the 
investigated factors with the outcome, i.e. the disease of interest. To use the word 
risk factor, the event must precede disease onset. In an observational cross-
sectional study design, data on both explanatory factors and outcome are 
measured simultaneously at a specific point in time, and it is not possible to make 
a distinction between which variable is the cause and which is the effect. Only 
associations between the investigated variables and the effect can thus be 
measured.  
Another type of observational study is the case-control study. Two groups 
differing in outcome are compared to identify factors that may contribute to 
disease development. In case-control studies, subjects who have the disease 
(“cases”) are compared with those who do not have the disease (“controls”). 
Even though the identified factors precede disease development, causal 
inference cannot be claimed (Rothman, 2012). Following an association study 
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using a case-control population, the identified genetic risk factors for complex 
diseases such as diabetes can be defined as associated with an increased risk of 
developing the disease. The particular risk for any given genetic risk factor needs 
to be defined specifically. Typically, for complex diseases there are multiple 
genetic and environmental risk factors that interact, and these factors combined 
will determine the risk for the individual. 
In the following sections risk factors for overweight, obesity and DM will be 
discussed simultaneously, since the same or similar factors appear to be asso-
ciated with all the conditions, making a distinction between them difficult. 
1.4.1 Non-modifiable factors   
Age 
Increasing age has been associated with an increased risk of DM in both people 
and cats. Most diabetic cats are > 8 years of age, with a peak incidence between 
10 and 13 years of age (Panciera et al., 1990; Baral et al., 2003). Mature age is 
also associated with an increased risk of overweight and obesity in cats (Russell 
et al., 2000; Lund et al., 2005; Courcier et al., 2012). In people, it has been 
shown that β-cell function deteriorates with age. The age-associated decline of 
β-cell function likely plays a role in the increased prevalence of abnormal 
glucose tolerance encountered with age (Chiu et al., 2000). 
Sex  
In cats, it has been shown that males are more prone to develop DM (Panciera et 
al., 1990; McCann et al., 2007; Prahl et al., 2007; Lederer et al., 2009). 
However, male cats are also more prone to develop obesity, which will 
contribute to an increased DM risk (Scarlett et al., 1994; Appleton et al., 2001; 
Lund et al., 2005; Colliard et al., 2009; Courcier et al., 2010). In people on the 
other hand, sex has not been associated with the risk of developing T2DM, with 
the exception of gestational DM, a condition where women develop DM during 
pregnancy (Chu et al., 2007; Chen et al., 2012). 
Neutering is routinely performed in many domestic cats worldwide, to 
prevent from over-population, and is here considered a non-modifiable risk 
factor. Neutering has been recognised as a risk factor for DM in both male and 
female cats (Panciera et al., 1990; McCann et al., 2007; Prahl et al., 2007), 
although it did not remain as a risk factor in the multivariable models in these 
studies (McCann et al., 2007; Prahl et al., 2007). It is possible that the effect of 
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neutering on DM risk is a reflection of an increase in both age and obesity, rather 
than an effect of the gonadectomy itself (Prahl et al., 2007).  
Breed and genetic susceptibility 
Breed as a potential risk factor for feline DM has been investigated, but most 
studies have failed to identify other breeds than the Burmese as high risk breeds 
for DM. The Burmese cat (Figure 5) had an increased risk for DM in studies from 
Europe, Australia, and New Zeeland, but not from the US (Panciera et al., 1990; 
Rand et al., 1997; Wade et al., 1999; McCann et al., 2007; Prahl et al., 2007; 
Lederer et al., 2009).  
 
Figure 5. A Burmese cat. By user: Heikki Siltala (URK cat show Kirkkonummi 2013-10-13), CC 
BY 3.0, via Wikimedia Commons. 
26 
 
However, the European/Australian and the American Burmese breed lines 
have been kept separate since the 1970s, and can thus be considered to represent 
two different subpopulations (Alhaddad et al., 2013).  
The cause of the predisposition to DM in the Burmese cats is unknown, but 
likely genetic (O'Leary et al., 2013). A dyslipidaemia is present in the breed, and 
is suspected to be associated with insulin resistance and thereby an increased 
risk of DM (Kluger et al., 2009; Kluger et al., 2010; Lee et al., 2013). Lean 
Burmese cats had aberrant gene expression patterns and cholesterol lipoprotein 
fraction profiles that mimicked the profile of obese domestic cats, suggesting a 
propensity for obesity and insulin resistance, and supporting the hypothesis that 
these Burmese cats were in a prodromal obese metabolic state (Lee et al., 2013).  
Ethnicity in people has also been associated with differences in T2DM risk 
(Ravussin et al., 1994; Cowie et al., 2010; Chatterjee et al., 2017), with the Pima 
Indians as a well-known example of an indigenous population with a very high 
prevalence of T2DM, with more than half of the adults affected (Barceló & 
Rajpathak, 2001). The “westernisation” process has been proposed to play a 
major role in the DM epidemic in people. Several populations previously free of 
DM, have recently been shown to have a high prevalence of DM, and it is possible 
that the progression to DM in different ethnic groups may be determined by a 
prevalent insulin resistance in some, and by β-cell dysfunction in others (Abate 
& Chandalia, 2003). 
Type 2 DM depends on multiple genetic loci as well as environmental factors 
as previously discussed, and is known as a complex polygenic disorder. In 
people, more than 100 susceptibility loci have so far been detected by genome-
wide association studies (Gaulton, 2017). Most of these genes seem to be related 
to β-cell function rather than to obesity or insulin resistance, which was 
anticipated earlier. Beta cell dysfunction is more severe than insulin resistance, 
since insulin secretion is impaired, whereas with insulin resistance, insulin may 
still be secreted. As β-cell function deteriorates, hyperglycaemia develops 
initiating the onset of T2DM (Cerf, 2013). Likely, there are also differences in 
the locations of risk alleles and frequencies of occurrence of particular risk 
alleles across different ethnic groups (Chen et al., 2012).  
In cats, very little is known about the genetic background in DM pathogenesis. 
Insulin sensitivity varies between individual cats, and it is speculated that an 
underlying low insulin sensitivity in some cats is genetically determined 
(Appleton et al., 2001). Others have investigated heritability for DM within the 
Burmese cat breed (Wade et al., 1999; O'Leary et al., 2013). Heritability was 
estimated to be around 9%, assuming that all included animals with unknown 
status were unaffected from DM. Authors suggested a dominant expression with 
the risk allele frequency at 15% with 60% penetrance to be the best fitting 
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genetic model in this breed (O'Leary et al., 2013). Others, however, stated that 
the condition was not sex linked, and unlikely to be dominant (Wade et al., 
1999). Apart from these two pedigree analyses on Burmese cats, a recent study 
found that a mutation in the melanocortin 4 receptor (MC4R) gene was associated 
with DM in overweight domestic shorthaired cats. Mutations in this gene are the 
most common single genetic cause of human obesity, but an association between 
presence of the mutation and overweight has not been demonstrated in cats (Xi 
et al., 2012; Forcada et al., 2014).  
1.4.2 Modifiable factors 
Overweight and obesity  
Overweight and obesity are important factors contributing to insulin resistance 
in both cats and people, and also highly important risk factors for DM (Biourge 
et al., 1997; Scarlett & Donoghue, 1998; German, 2006; Scott-Moncrieff, 2010; 
Chen et al., 2012; Hoenig, 2012; Bjornvad et al., 2014; Hoenig, 2014; Osto & 
Lutz, 2015; Clark & Hoenig, 2016). Scarlett and Donoghue found an almost 
fourfold increased risk of DM in obese cats (Scarlett & Donoghue, 1998).  
In people, overweight can be defined as having a BMI greater than 25, and 
obesity if above 30, as mentioned previously (Guh et al., 2009). Cats have an 
optimal body condition when scored 5/9, are considered overweight when scored 
6–7/9, and obese when scored 8–9/9, when using the 9-grade scale (Brooks et 
al., 2014). When using a 5-grade scale, 3 is considered an optimal BCS, while 
scores below or above 3 are considered as being underweight or overweight, 
respectively (Baldwin et al., 2010).    
In people, obesity, especially so called central obesity, increases insulin re-
sistance by a number of mechanisms. Enhanced lipolysis will occur, since the 
normal anti-lipolytic effects of insulin will be diminished when adipose tissue 
has become resistant to the effects of insulin. This will contribute to increased 
release of free fatty acids (FFA) from the adipocytes. Free fatty acids negatively 
affect the liver by impairing insulin uptake, thereby contributing to an increased 
gluconeogenesis and glucose release, creating a vicious circle (Kopelman, 
2000). Moreover, adiponectin concentrations are lower in obesity, leading to a 
decreased stimulation of fatty acid oxidation further contributing to insulin 
resistance (Kahn et al., 2006).  
Several other adipocyte-derived factors are also believed to play a role in the 
development of insulin resistance, for example tumour necrosis factor-α and 
interleukin-6 (Kahn et al., 2006). In cats, obesity has also been shown to be 
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associated with insulin resistance, as showed by Hoenig et al. using a euglycae-
mic hyperinsulinaemic clamp, the gold standard method for evaluating insulin 
resistance. Glucose sensitivity in obese cats was only 40% of that of lean cats 
(Hoenig et al., 2006). 
Physical inactivity  
In humans, it is well known that a sedentary lifestyle is associated with an 
increased risk for both obesity and T2DM (Chatterjee et al., 2017). Inactivity  has 
also been shown to induce changes consistent with insulin resistance in people 
(Hamburg et al., 2007). In cats, indoor confinement and physical inactivity have 
been associated with an increased risk of both obesity and DM (Scarlett et al., 
1994; Robertson, 1999; Slingerland et al., 2009).   
Dietary factors 
Several studies have investigated associations between different types of food 
and obesity or DM in cats, but results have been inconclusive. It has been 
hypothesised that the change in diet, from the feral cats’ low-carbohydrate, high-
protein diet to the high-carbohydrate diet given to many domesticated cats today, 
is partially responsible for the increase in overweight and DM seen in cats (Rand 
et al., 2004). Cats are strict carnivores, and a cat’s natural diet consists of small 
prey with a low carbohydrate content (Dierenfeld et al., 2002), but many 
commercial diets today are moderate to high in carbohydrate content. In one 
study, it was shown that overweight cats were more likely to be fed dry foods 
purchased from veterinarians or other non-grocery retailers, or to receive 
specialty or prescribed diets (Scarlett et al., 1994). In younger cats, an 
association between eating predominantly dry food and overweight has been 
detected (Rowe et al., 2015; Rowe et al., 2017). Others did not detect asso-
ciations between type of diet and the cats’ weight (Robertson, 1999). Slingerland 
et al. investigated associations between diet and DM, but their results indicated 
that the proportion of dry food in a cat’s diet was not an independent risk factor 
for DM (Slingerland et al., 2009).  
Type of feeding regime has also been investigated as a risk factor for both 
obesity and DM. Again, studies have shown different results. Ad libitum feeding 
has been associated with a higher body condition compared to meal-feeding for 
cats fed a canned diet, but not for cats on a dry-food diet (Russell et al., 2000). 
Another study found owners feeding their cats twice or three times a day to be 
more likely to have overweight or obese cats than those who fed ad libitum 
(Courcier et al., 2010). Yet others found no associations between feeding 
management and risk of obesity (Allan et al., 2000).  
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Eating behaviour has been analysed as a potential risk factor for obesity and 
DM in both cats and humans. In people, eating slowly was associated with a 
lower caloric intake and an enhanced satiety (Andrade et al., 2008). Diabetic 
Burmese cats tended to more often be described by their owners as “greedy 
eaters” compared to age- and gender matched nondiabetic Burmese cats, 
although the difference was not statistically significant (Lederer et al., 2003).  
Drugs 
Corticosteroid treatment, and administration of progestins such as megestrol 
acetate, have been reported as risk factors for feline DM (Rios & Ward, 2008b). 
However, most of these studies are intervention studies, where cats experi-
mentally have been given high doses of one or both of these types of drugs, in 
some cases leading to DM or glucose intolerance (Buse et al., 1957; Middleton 
& Watson, 1985; Peterson, 1987; Hoenig et al., 2000). Authors concluded that 
if cats are treated with a glucocorticoid or megestrol acetate, overt DM is most 
likely to occur in animals with a subclinical DM present (Peterson, 1995). In 
Sweden, medroxyprogesterone acetate is used in cats and megestrol acetate is 
not available. Risk factor analysis has shown corticosteroid treatment to be a risk 
for DM development in the univariate analysis, but not in the following 
multivariate model (McCann et al., 2007).  
1.5 Clinical features of diabetes mellitus in cats 
1.5.1 Pathophysiology 
There are striking pathophysiological similarities between diabetic cats and 
people. In people, insulin resistance in tissues, will lead to an increased 
production of insulin from pancreatic β-cells in order to maintain normal glucose 
homeostasis. If β-cells are incapable of this task, glucose concentrations will rise 
and T2DM will evolve. Reduced β-cell function is present in certain groups of 
people at increased risk for DM, and it has been shown that β-cell function is 
heritable (Kahn et al., 2014). In the diabetic human pancreas, the number of 
β-cells is reduced. In diabetic cats, there is also a mean loss of β-cells of 
approximately 50% (O'Brien et al., 1986). The reason for this β-cell loss is 
multifactorial, and includes glucotoxicity and deposition of amyloid. Chronic 
hyperglycaemia impairs insulin secretion by increased apoptosis of the β-cells, 
mediated by activation of oxidative stress as a result of increased generation of 
reactive oxygen species (Del Prato, 2009). Amyloid is a proteinaceous deposit 
with a β-sheet structure. Amylin, or islet amyloid polypeptide (IAPP), is a 
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polypeptide hormone co-secreted with insulin from the pancreatic β-cells, that 
forms the amyloid deposits present in the pancreas of most diabetic people and 
cats (Johnson et al., 1989a; O'Brien, 2002; Westermark et al., 2011; Herndon et 
al., 2014). Islet amyloidosis (Figure 6) has been shown to occur in only a limited 
number of species (e.g. people, macaques and cats), and not in rodents or dogs; 
animal species in which a diabetic syndrome similar to T2DM in people does not 
seem to develop spontaneously (Johnson et al., 1989b; O'Brien et al., 1993; 
Höppener et al., 2002; O'Brien, 2002). 
 
Figure 6. An islet of Langerhans from a healthy cat pancreas (A), and an islet with severe 
amyloidosis from a diabetic cat (B). Photo: Erika Karlstam. 
It has been debated whether the islet amyloid present in T2DM is a cause or 
merely a consequence of the disease. It is possible that islet amyloidosis can be 
both a cause and a consequence, as it is induced by insulin resistance (stimulating 
both insulin and IAPP secretion), and subsequently contributes to the develop-
ment of insulin insufficiency by promoting β-cell failure, since the location of 
the amyloid can impair the supply of glucose and other nutrients to the islet cells 
(Höppener et al., 2002). 
Other types of DM in cats can occur, for example as a consequence of 
overproduction of hormones with an insulin-antagonistic effect, such as cortisol 
(hyperadrenocorticism) and growth hormone (hypersomatotropism or acro-
megaly) (Niessen et al., 2015). Pancreatitis and other pancreatic diseases are 
disorders that can lead to widespread damage to the pancreas and the islets of 
Langerhans, with subsequent β-cell failure and DM development (Rand, 2013). 
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1.5.2 Diagnosis 
Diabetes mellitus in cats is usually diagnosed based on the presence of clinical 
signs and persistent hyperglycaemia. Classic clinical signs of feline DM include 
polyuria, polydipsia, lethargy, weight loss, and polyphagia. Stress hyper-
glycaemia and glycosuria must be excluded, as stress in cats can cause a marked 
transient hyperglycaemia. Measurement of serum fructosamine, a glycated 
plasma protein, is helpful to confirm a diagnosis, as it is indicative of the average 
blood glucose concentration during approximately the preceding week (Link & 
Rand, 2008; Sparkes et al., 2015). In people, HbA1c, or glycated haemoglobin, 
is used as an index of mean plasma glucose over the preceding weeks to months. 
HbA1c is a “weighted” average of the blood glucose levels during the preceding 
120 days, which is the lifespan of erythrocytes. The glucose concentration from 
the last month contributes to approximately 50% of the final result (Rohlfing et 
al., 2002). 
In people, the concentration of C-peptide can be measured as a marker for 
endogenous insulin production. C-peptide is removed from proinsulin when 
insulin is formed, and it is produced in equal amounts to insulin. It can be used 
to distinguish patients with T1DM from T2DM, because with time, C-peptide 
becomes undetectable in T1DM patients. C-peptide can be measured even if the 
patient receives insulin injections (Clark, 1999; Jones & Hattersley, 2013). 
C-peptide assays are currently not available for cats. 
1.5.3 Treatment 
Treatment of diabetic cats aims at controlling or eliminating clinical signs by 
achieving good glycaemic control. This usually involves insulin treatment 
together with lifestyle adjustments, such as diet and weight control (Sparkes et 
al., 2015).  
In human T2DM patients, lifestyle adjustments with focus on diet and obesity 
treatment, alone or with the addition of oral drugs, are generally appropriate as 
initial treatment, depending on severity of the disease. Metformin remains the 
therapy of choice for people with T2DM (Chatterjee et al., 2017). Metformin 
reduces glucose output from the liver, enhances insulin sensitivity, stimulates 
glucagon-like peptide (GLP)-1 secretion, and lowers HbA1c concentrations 
without causing hypoglycaemia. Targeting the incretin system, of which GLP-1 
is a member, has become an important novel therapeutic approach for treating 
T2DM. Incretins are a group of metabolic hormones that are produced in the 
intestines and released in response to food intake. They augment the secretion 
of insulin from the β-cells, thereby stimulating a decrease in blood glucose 
levels. The incretin effect explains the difference between responses to oral and 
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intravenous glucose administration, where glucose given orally produces a 
greater insulin response than that of an intravenous infusion. In people, the 
incretin effect is reduced in T2DM patients and in obesity (Muscelli et al., 2008; 
Meier & Nauck, 2010; Nauck, 2011). Concentrations of the incretin glucagon-
like peptide GLP-1 were lower in obese than in lean cats. The low concentrations 
might indicate a contribution of GLP-1 to the lower insulin sensitivity of obese 
cats, but this hypothesis needs to be further investigated (Hoenig et al., 2010). 
Two drug classes targeting the incretin system have been developed; GLP-1 
receptor agonists and dipeptidyl peptidase (DPP)-4 inhibitors (Højberg et al., 
2009). The DPP-4 inhibitors act by blocking the enzyme DPP-4, responsible for 
the degradation of incretins such as GLP-1. 
In contrast to cats, people are often diagnosed with T2DM or prediabetes when 
their blood glucose is only mildly elevated, and most often years before the 
hyperglycaemia would cause clinical signs. Since the DM diagnosis in cats is 
usually made when blood glucose concentrations are much higher, this 
presumably occurs at a later stage when the pancreatic β-cell mass is already 
significantly decreased. The window of opportunity to treat by targeting the 
incretin system might therefore be smaller for diabetic cats (Gilor et al., 2016b). 
Exenatide, a GLP-1 mimetic, was well tolerated when given to obese cats for 12 
weeks, and tended to decrease body weight even without dietary changes 
(Hoelmkjaer et al., 2016). It potentiates insulin secretion in healthy cats (Gilor 
et al., 2011), and has also been used in a pilot study on diabetic cats, where it 
was not associated with local or systemic adverse effects (Riederer et al., 2016). 
In healthy cats, a DPP-4 inhibitor significantly reduced glucagon output, and 
increased insulin output, after an intravenous glucose tolerance test (Furrer et 
al., 2010). The potential usefulness of incretin therapy in diabetic cats remains 
to be established.  
In cats, in contrast to most human T2DM patients, insulin treatment is usually 
necessary at diagnosis. Insulin is often administered subcutaneously twice daily. 
Insulin-induced hypoglycaemia should be avoided, sometimes at the expense of 
allowing periods of hyperglycaemia. The owner’s concerns and expectations 
will influence the level of glycaemic control to be aimed for (Sparkes et al., 
2015). As insulin treatment is preferable in cats, oral hypoglycaemic drugs are 
infrequently used (Sparkes et al., 2015). Metformin is of limited value in diabetic 
cats (Nelson et al., 2004), and an alternative oral agent, glipizide, is often 
ineffective (Sparkes et al., 2015).  
Secondary or concurrent diseases such as diabetic neuropathy, infections, 
chronic pancreatitis, acromegaly, and dental problems, as well as other factors 
which might contribute to insulin resistance, such as corticosteroid treatments, 
should be addressed (Rand, 1999; Rios & Ward, 2008a; Stanko & Izakovicova 
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Holla, 2014; Sparkes et al., 2015). Suspected acromegaly can be diagnosed with 
a combination of typical clinical findings, hormonal tests (insulin-like growth 
factor (IGF)-I and feline growth hormone) and intracranial imaging (computed 
tomography or magnetic resonance imaging) (Niessen, 2010). In cats, IGF-I 
concentrations > 1,000 ng/mL have been suggested as a tentative diagnosis of 
acromegaly (Niessen et al., 2007).  
In people, the bidirectional association between DM and inflammatory 
periodontal disease is well-known (Taylor et al., 1996; Stanko & Izakovicova 
Holla, 2014). In cats, studies in this field are lacking. However, anecdotal reports 
indicate that diabetic cats commonly have dental disease and chronic gingivitis 
(Diehl, 1995). There are also anecdotal reports where insulin-treated diabetic 
cats had markedly improved glycaemic control when dental disease was treated 
(Martin & Rand, 2000). 
Lifestyle interventions for a diabetic cat typically includes weight loss 
management and dietary interventions. Increased exercise is encouraged as a 
useful adjunct to the weight management (German, 2006). Wet foods can be 
beneficial, as they tend to lower the caloric consumption compared to dry food, 
which often is more calorie-dense due to the lower water content (Wei et al., 
2011). A low-carbohydrate diet is recommended to achieve better glycaemic 
control (Frank et al., 2001; Mazzaferro et al., 2003; Bennett et al., 2006). The 
low-carbohydrate dietary recommendations have replaced the earlier recommen-
dations of a high-fibre diet to diabetic cats (Nelson et al., 2000). Interestingly, 
regarding treatment of diabetic cats, already in the 1960’s Joan Joshua stated the 
following: 
 
“The cat. A much more rewarding species to treat. Diet is not effective since most 
cats are already on a very low carbohydrate intake anyway.” (Joshua, 1963) 
 
This context has changed dramatically since the 1960’s, and today, commercial 
dry food is a typical diet for domestic cats. As the carbohydrate content in 
commercial dry cat food constitutes approximately 20–40% of the metabolisable 
energy, it cannot be considered to be a low-carbohydrate feed (Villaverde & 
Fascetti, 2014).  
1.5.4 Remission 
Resolution of peripheral insulin resistance in cats with T2DM together with good 
glycaemic control may result in diabetic remission (Scott-Moncrieff, 2010). 
Remission can be defined as the ability to maintain euglycaemia without insulin 
therapy for at least 4 consecutive weeks, without the reappearance of clinical 
signs (Zini et al., 2010; Gottlieb et al., 2015). Cats in remission should remain 
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on a low-carbohydrate diet and kept in optimal body condition (Sparkes et al., 
2015). Remission is more likely to occur with good glycaemic control and early 
institution of treatment (Zini et al., 2010; Gottlieb & Rand, 2013; Nack & 
DeClue, 2014). 
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The hypothesis underlying this thesis was that the lifestyle change in domestic 
cats during the last century would be associated with both overweight and DM. 
The main aims were to identify new potential risk factors for DM in cats, to 
confirm previously identified risk factors, and to increase understanding of 
disease pathogenesis.  
 
The specific aims were to: 
 
 Determine the general incidence of DM in Swedish cats. 
 Determine incidence rates (IRs) for demographic risk factors for DM, such as 
age, breed and sex. 
 Investigate associations between environmental risk factors and DM in cats. 
 Determine the prevalence of overweight in cats. 
 Investigate associations between overweight in cats and demographic and 
environmental factors. 
 Explore the predisposition of the Burmese cat breed to DM by studying the 
metabolic profile in the Burmese, Birman and Maine coon breeds. 
 
 
 
 
 
 
 
  
2 Aims 
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The methods used are described in detail in each respective paper. Study I 
focused on demographic (non-modifiable) risk factors for feline DM and used 
data from the Agria Pet Insurance company database. Owners were recruited 
from the database for participation in a questionnaire study where environmental 
(modifiable) risk factors for DM were assessed (study II). Study III investigated 
factors associated with overweight in a cross-sectional study, and included data 
from hospital records obtained for cats visiting the University Animal Hospital, 
Swedish University of Agricultural Sciences (SLU), and questionnaire data from 
the non-diabetic control group used in study II. Study IV included clinical data 
and blood samples from healthy cats, visiting the University Animal Hospital, 
SLU, and the Anicura Bagarmossen Animal Referral Hospital (Figure 7). 
 
Figure 7. Overview of number of included cats in each study, and types of data and sample material 
used for the studies included in this thesis. 
Swedish cat population (n = 1.2 million)
Agria Pet 
Insurance 
University Animal 
Hospital (SLU)
Anicura Bagarmossen 
Animal Hospital
Study I Study II Study III Study IV
n = 504.688 n = 2.066 n = 2.737 n = 94
Insurance 
data 
Clinical data,
blood samples
Hospital records, 
questionnaire data
Questionnaire 
data
3 Comments on materials and methods 
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3.1 Measuring disease frequency 
3.1.1 Incidence of diabetes mellitus in insured cats (paper I) 
As mentioned previously, determining IRs require knowledge about the 
population at risk of developing the disease. We used data on all cats insured in 
the Agria Pet Insurance Company’s database during a 5-year period 
(2009−2013) to investigate the incidence of DM in Swedish cats. It is estimated 
that more than one third of all cats in Sweden are insured, and Agria Pet 
Insurance Company is the largest pet insurance company in Sweden. The 
database includes records of both healthy and sick cats, and is believed to fairly 
represent the Swedish cat population, although there is a larger proportion of 
purebred than domestic cats that is covered by an insurance (Egenvall et al., 
2010). The exact time each cat was covered by the insurance was calculated and 
summarised. Cats were at risk from start of year 2009 or start of the insurance if 
cats entered the system at a later date, to the end of 2013, or until the date of a 
DM diagnosis, death, or withdrawal from the insurance. The time at risk is 
expressed as cat-years at risk (CYAR) (Figure 8). All cases of DM were counted, 
and IRs were thereafter calculated as number of cases with DM divided by the 
total time at risk.  
Figure 8. Each cat in the insurance database contributes with time at risk for developing DM. Before 
entry into the insurance program, or in case of death (†), diabetes mellitus (DM) diagnosis, or 
withdrawal from the insurance, the cat does not contribute to time-at-risk as illustrated in the figure. 
The exact time-at-risk for each individual cat is calculated as cat-years at risk (CYAR) and 
thereafter summarised. 
Cat no. 1
Cat no. 2
Cat no. 3
Cat no. 4
Cat no. 5
Cat no. 6
2009 20132010 2011 2012
DM
5 cat-years
4 cat-years
3½ cat-years
2 cat-years
1½ cat-years
3 cat-years
Etc. Sum CYAR
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A strength with using entries in an insurance database as a study population 
is the considerable size of the registry, which allows stratifications by for 
example age, sex and breed. We also stratified on study year, since we wanted 
to examine if the incidence of DM in Swedish cats is increasing or not. 
3.1.2 Prevalence of overweight in two cohorts of cats (paper III) 
In many circumstances, calculating the incidence of a condition is unfeasible, 
and researchers therefore choose to report disease occurrence as prevalence. The 
prevalence is often used to measure chronic diseases such as obesity which have 
a long duration, and time of onset can be insidious and difficult for the individual 
to pinpoint. Many veterinary studies report hospital prevalence. This can be 
misleading, as the prevalence of a disease is likely higher when measured at a 
hospital where fewer healthy individuals are normally encountered, compared to 
the general population. 
Since obesity has been reported as an important risk factor for feline DM 
(Scarlett & Donoghue, 1998), we decided to examine if cat breeds associated 
with an increased risk of DM would also be associated with overweight. We did 
this by investigating the prevalence of overweight in two cohorts of cats. The 
first cohort consisted of cats visiting the University Animal Hospital, SLU, 
Uppsala, Sweden, during years 2013 to 2015. The second cohort consisted of the 
non-diabetic control cats used in study II, whose owners answered a web 
questionnaire. Medical records and questionnaire data were used from each 
cohort of cats. Only cats older than one year of age at the time of visit to the 
hospital were included. All medical records where the cat’s body condition were 
scored using a 9-grade scale (Laflamme, 1997) were used for further analysis. 
For the questionnaire cohort where owners scored their cat, a 5-grade scale was 
used (Baldwin et al., 2010). The 5-grade was selected because of its simplicity 
and user-friendliness. 
If the body condition was scored from 6 to 9 in the medical record, the cat 
was considered overweight, and a score of 5 or lower was considered as not 
being overweight. The overweight group included both overweight and obese 
cats. Cats in the questionnaire cohort were considered overweight if scored by 
owners as grade 4 or 5, and not overweight if scored 3 or lower. Prevalence of 
overweight was calculated as the percentage of overweight cats in each cohort. 
A major difference between the two cohorts was the examiner of the cats’ body 
condition; in the first cohort the cats were examined using a 9-grade scale by 
either a veterinarian or a veterinary student, and in the second cohort owners 
judged their cats’ body condition on a 5-grade scale with the help of illustrations 
and accompanying descriptions (Baldwin et al., 2010). 
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3.2 Factors associated with disease 
3.2.1 Demographic risk factors for diabetes mellitus (paper I) 
In this case-control study, we investigated if non-modifiable demographic 
factors such as age, breed, and sex were associated with risk of DM in cats. 
Information on neutering status was unavailable in the database, and sex was 
defined as male or female. Data used consisted of all records in the Agria Pet 
Insurance’ database during 2009 to 2013. Incidence rates were calculated as 
number of diabetic cats divided by CYAR. Dividing two IRs, e.g. the IR for male 
versus female cats, renders the incidence rate ratio (IRR), or rate ratio. We 
calculated IRRs to compare the IRs between male and female cats, age groups, 
and between different cat breeds and all other purebred cats or all other cats. A 
95% confidence interval (CI) was calculated for each IRR. If the CIs for the IRR 
did not include 1, it was considered evidence that the groups were significantly 
different from each other.  
3.2.2 Environmental risk factors for diabetes mellitus (paper II) 
To complement data from study I, where non-modifiable demographic risk 
factors for DM in Swedish cats were assessed, we decided to extend our 
knowledge by including assessment of modifiable environmental risk factors, 
using the same cohort of cats from the Agria Pet Insurance database. An 
invitation to participate in this questionnaire study was sent out to owners of 
diabetic cats with a diagnosis received during 2009−2013 (i.e. the same cats 
identified as DM cases in study I). A non-diabetic control group, four times larger 
in size than the diabetic group as suggested by Linden and Samuels (Linden & 
Samuels, 2013), was recruited from the same database and time period, with cats 
matched on birth year with the diabetic cats. No other selection was made for 
the control group.   
Owners received a web address to the questionnaire, where a maximum of 
48 questions were provided. The questionnaire included questions on the cat’s 
birth year, breed, sex, and neutering status, as well as questions related to activity 
level, access to outdoors, type of diet, feeding regime, eating behaviour, body 
condition etc. Sex was defined as male or female, and neutering status as intact 
or neutered. Data were analysed with multiple logistic regression, with DM as 
the dependent variable, after excluding clearly non-significant variables 
(P > 0.15) in a univariable logistic regression. A backwards stepwise elimination 
approach was used to exclude variables based on a lowered Akaike information 
criterion (AIC), as a measure of best goodness of fit of the final statistical model. 
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Odds ratios (OR) were calculated with 95% CIs. The significance level was set 
as P < 0.05.  
There were interactions present between some of the variables assessed, and 
these interactions were also included in the multiple logistic regression model if 
P < 0.15. An interaction can be interpreted as a combination of two variables 
where the combination itself leads to a different effect on the outcome. This 
occurs when the simultaneous influence of two variables on the outcome is not 
additive. If two variables interact, the relationship between each of the inter-
acting variables and the outcome depends on the value of the other interacting 
variable. Therefore, the two interacting variables need to be interpreted in 
context to correctly asses their effect on the outcome.  
3.2.3 Factors associated with overweight (paper III) 
In this cross-sectional retrospective study, we investigated factors associated 
with overweight in cats. We were interested in whether the risk factors 
previously identified for DM would be similar to the factors associated with 
overweight. In particular, we wanted to know if the breed predisposition to DM 
was similar to the breed predisposition to overweight, and if breeds with a low 
risk of DM would be similar to the breeds with a low prevalence of overweight.  
As mentioned previously, data from two cohorts of cats was used in this 
study. The first cohort included cats visiting the University Animal Hospital 
during 2013 to 2015, and medical records were used. From these records, 
information on the cats’ age, breed, sex, neutering status, diagnosis assigned 
when visiting the hospital, and information on BCS were collected. The diagnosis 
can also include clinical signs, such as fever or anorexia. Sex was defined as 
male or female, and neutering status as intact or neutered. If BCS was 6 or higher 
on the 9-grade scale used, cats were grouped as overweight, and if BCS was 5 or 
lower into the group not overweight.  
The second cohort comprised cats insured by the Agria Pet Insurance 
Company during 2009 to 2013. Data from the questionnaire from the non-
diabetic control group in study II was used. Data included information about the 
cats’ age, breed, and sex, type of diet, eating behaviour, and activity level. Cats 
were considered overweight if scored 4−5 (on a 5-grade scale), and not 
overweight if scored 3 or lower. A multiple logistic regression analysis with 
backwards stepwise removal of non-significant variables was applied to each 
cohort based on a lowered AIC, with overweight as the response variable of 
interest. Odds ratios were calculated with 95% CIs. The significance level was 
set as P < 0.05.  
 
42 
 
3.3 Burmese cats predisposed to diabetes mellitus 
(paper IV) 
The Burmese cat breed has been identified as a high-risk breed for developing 
DM in previous studies (Rand et al., 1997; McCann et al., 2007; Lederer et al., 
2009). A dyslipidaemia is present in the breed, possibly causing this pre-
disposition to DM (Kluger et al., 2009; Kluger et al., 2010). Therefore, we 
decided to study the metabolism in the Burmese cat breed. Healthy Burmese cats 
were recruited to the study in collaboration with the Swedish Burmese cat club. 
All cats were examined at the University Animal Hospital, Uppsala, or at the 
Bagarmossen Anicura Referral Hospital, Stockholm, during two sampling 
periods, the first in 2013, and the second in 2015 to 2016. Healthy cats from a 
low-risk breed for DM (the Birman breed) and a medium-risk breed (the Maine 
coon (MCO)) were used as controls, and sampled in 2015 to 2016. Samples from 
94 cats (46 Burmese cats, 23 Birman cats, and 25 MCO cats) were analysed for 
serum biochemistry parameters (alanine aminotransferase (ALAT), creatinine, 
fructosamine, FFA, and lipoprotein fractions), and hormones (insulin, adipo-
nectin, and IGF-I analyses performed with enzyme-linked immunosorbent assay 
(ELISA)). Analysis of the serum metabolome with nuclear magnetic resonance 
(NMR) spectroscopy was performed in 63 of the cat samples, since 31 of the 
Burmese samples had to be excluded due to differences in sample handling. 
Nuclear magnetic resonance spectroscopy is an analytical technique that has 
emerged as a promising approach to identify new biomarkers, and has been 
applied to research on many different diseases in people, e.g. T2DM, and other 
metabolic traits. The metabolic aetiology of T2DM makes it a suitable condition 
to be characterised with metabolomics techniques such as NMR or liquid 
chromatography mass spectrometry (LC-MS) (Orešič, 2009; Connor et al., 2010). 
Another advantage with metabolomics is the possibility to identify biomarkers 
that can predict disease before overt symptoms have manifested, enabling 
interventions that may delay or even prevent a progression to T2DM. The 
metabolomics techniques have identified several metabolites associated with 
T2DM, insulin resistance and prediabetes in people (Gall et al., 2010; Wang et 
al., 2011; Floegel et al., 2013). We wanted to investigate if Burmese cats might 
have a metabolic profile compatible with insulin resistance patterns in people, 
which might anticipate a progression into DM at a later stage.  
A multivariate statistical model was used to investigate the effects of breed, 
weight, and BCS on the concentrations of the serum biochemistry variables 
creatinine, ALAT, fructosamine, FFA, very low-density lipoprotein-triglycerides 
(VLDL-TG), high-density lipoprotein (HDL)-cholesterol and concentrations of the 
hormones insulin, adiponectin, and IGF-I. The model was not adjusted for age, 
sex or neutering status as these parameters did not differ between groups. 
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For NMR metabolites, a principal components analysis was used, followed by 
a one-way ANOVA with a post-hoc Tukey test, or a Kruskal-Wallis test for not 
normally distributed data, applied on each metabolite with breed as the 
explanatory variable. Thereafter correction for multiple testing was done 
(Benjamini & Hochberg, 1995), and a multivariate partial least squares 
discriminant analysis (PLS-DA) was performed. A univariate regression model 
was finally applied to all metabolites differing significantly between breeds from 
the multivariate approach, to adjust for weight and BCS, which differed between 
breeds. For normally distributed data, concentrations were reported as least 
square means with 95% CI. Non-normally distributed data were logged for 
analysis, and least square means were back-transformed and reported as 
geometric means, with 95% CI. 
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4.1 Measuring disease frequency 
4.1.1 Incidence of diabetes mellitus in cats (paper I) 
In total, 504,688 individual cats contributed to the study. The number of CYAR 
was 1,229,669, which was used to calculate the IR of DM. 1,432 cases of DM was 
registered, giving a general IR of 11.6 cases per 10,000 CYAR (95% CI, 
11.0−12.2). The IRs were similar across years 2009 to 2013.  
4.1.2 Prevalence of overweight in cats (paper III) 
The prevalence of overweight differed between the two cohorts (P < 0.0001). In 
the cohort of cats visiting an animal hospital, the prevalence of overweight was 
45%. In the questionnaire cohort, the prevalence of overweight was 22%.   
4.2 Factors associated with disease 
Risk factors associated with DM in cats were assessed in two studies. In study I, 
we focused on non-modifiable demographic risk factors such as age, breed and 
sex. In study II, a follow-up study was performed with investigation on 
modifiable environmental risk factors for DM in the same cohort of cats. Factors 
associated with overweight were assessed in study III. 
4 Results 
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4.2.1 Demographic risk factors for diabetes mellitus (paper I) 
Age 
The IR of DM was close to zero in young cats, and started to increase when cats 
were about 5 to 6 years of age, with a peak IR seen in cats at 13 years of age. In 
cats older than this, the IRs declined (Figure 9). 
 
Figure 9. Incidence rates (IRs) of diabetes mellitus per age category. IRs start to increase at around 
6 years of age, peak at 13 years of age, and decline in the geriatric cats. Error bars represent 95% 
confidence intervals. 
Breed 
Certain cat breeds had a higher IR of DM compared to all other cats, and also 
when compared to other purebreds. The most prominent was the Burmese breed, 
with an IR of 48.8 cases per 10,000 CYAR (95% CI, 31.0−65.7), compared to the 
IR of domestic cats of 12.1 (95% CI, 11.4−12.8). Other breeds with an increased 
risk of DM were the Russian Blue, Norwegian Forest cat, and Abyssinian. The 
IRR for Burmese cats versus all other purebred cats was 5.2 (95% CI, 3.6−7.6). 
The Bengal, Siberian, Birman, Ragdoll, British shorthair, Persian, and MCO 
breeds had a decreased risk of DM, with lower IRs compared to other cats. The 
IRR of DM for domestic cats compared to all purebreds was 1.2 (95% CI, 1.0−1.3). 
Sex 
The IR was higher for male cats (15.4 cases per 10,000 CYAR; 95% CI, 14.4−16.4) 
than for females (7.6 cases per 10,000 CYAR; 95% CI, 6.9−8.3), with an IRR for 
males compared to females of 2.0 (95% CI, 1.8−2.3). The increased risk of DM 
in male cats was seen in most breeds and was significant in several breeds, 
however not evident in the Burmese breed (Figure 10). 
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Figure 10. Incidence rates (IRs) of diabetes mellitus stratified on breed and sex. Most breeds have 
more male (blue bars) than female (orange bars) cats affected with diabetes mellitus. No 
discrimination was made based on neutering status. Only breeds with more than five cases of DM 
are shown in this graph. Error bars represent 95% confidence intervals. 
4.2.2 Environmental risk factors for diabetes mellitus (paper II) 
From this questionnaire study, answers from 2,066 cats were used for statistical 
analysis. Of these cats, 396 were from owners of diabetic cats and 1,670 from 
owners of non-diabetic control cats. In the multiple logistic regression, the 
variables breed, sex, vaccination status, corticosteroid injections, eating be-
haviour, and presence of other pets in the household remained associated with 
an increased risk of DM after stepwise removal of all non-significant variables. 
As expected, the Burmese and Norwegian Forest cat breeds showed an increased 
risk of DM, as did being male. Fully vaccinated cats were more often diagnosed 
with DM, as were cats receiving corticosteroid injections the year preceding a DM 
diagnosis. Living in a household with no other pets was associated with an 
increased risk of DM. Being considered a greedy eater was associated with 
increased odds of DM, compared to cats that had a nibbling eating behaviour. 
Two interactions remained significant in the final model. First, an interaction 
between BCS and type of diet, and secondly, an interaction between activity level 
and outdoor access versus indoor confinement. The variables included in an 
interaction always have to be interpreted in context. Being an indoor cat was 
associated with an increased risk of DM for the inactive and moderately active 
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cats, but such an association was not evident for the group of active cats. For the 
interaction between BCS and type of diet (Figure 11); the OR for DM was 
significantly higher for cats eating predominantly dry food in the normal-weight 
group (OR 3.8; 95% CI, 1.3−11.2), but in the overweight or underweight cats no 
associations between type of diet and DM risk were seen. On the other hand, 
regardless of type of diet, being overweight was always associated with an 
increased risk of DM. For cats on a diet consisting predominantly of dry food, 
the OR for developing DM was 2.3 (95% CI, 1.5−3.4) when comparing 
overweight cats with normal weight cats. For cats on a mixed diet the OR for DM 
was 2.6 (95% CI, 1.8−3.9), and for cats on a wet food diet 15.7 (95% CI, 
4.5−55.1), for overweight cats compared to normal weight cats. 
 
Figure 11. Odds ratios for diabetes mellitus for the interaction between body condition and type of 
diet. The interaction is shown within each body condition group (left), and diet group (right), 
respectively. Note that the log scale for the graph on the right reaches 100, in contrast to the left 
graph, which ends at 10, indicating a far greater effect of being overweight, regardless of diet type, 
compared to the effect of diet, where significance is present only within the normal weight group. 
Red data points and error bars show an increased risk of diabetes mellitus, whereas green indicates 
a decreased risk. Black points and error bars represent non-significant results. Error bars represent 
95% confidence intervals (CI). 
4.2.3 Factors associated with overweight in cats (paper III) 
The non-modifiable variables age, breed, and sex were significantly associated 
with overweight in the final multiple logistic regression model for both cohorts 
of cats. For the medical records cohort (n = 1,072), neutering status and type of 
diagnosis was associated with overweight. In the questionnaire cohort 
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(n = 1,665), type of food, eating behaviour, and activity level were factors 
associated with an increased, or decreased risk of overweight. In both cohorts, 
geriatric cats were less often overweight than mature cats. No individual cat 
breed was identified as being at an increased risk of overweight in this study, but 
in both cohorts, the Birman and Persian cat breeds showed a decreased risk of 
being overweight as compared with the domestic cats. When comparing 
domestic cats with all purebred cats, the domestic cats were more often 
overweight (OR 1.3; 95% CI, 1.0−1.7 in the medical records cohort, and OR 1.8; 
95% CI, 1.3−2.5 in the questionnaire cohort). Male cats were at increased risk of 
being overweight compared to females in both cohorts (OR 1.6; 95% CI, 1.3−2.1, 
and OR 1.4; 95% CI, 1.1−1.7, respectively).  
Several different diagnoses were associated with overweight in the group of 
cats visiting the animal hospital. We compared different diagnostic groups with 
diagnoses referring to the whole animal, including diagnoses such as “lethargy” 
or “fever”. Cats were more often overweight if they had a diagnosis related to 
the respiratory tract (OR 2.6; 95% CI, 1.4−4.8), skin (OR 2.4; 95% CI, 1.3−4.2), 
lower urinary tract (OR 2.2; 95% CI, 1.3−3.8), locomotor system (OR 2.1; 95% 
CI, 1.1−3.9), or trauma (OR 1.6; 95% CI, 1.0−2.4). 
Eating predominantly dry food was associated with being overweight when 
compared with eating predominantly wet food (OR 2.4; 95% CI, 1.4−4.0). Being 
a greedy eater was also associated with overweight, compared with preferring to 
nibble (OR 2.9; 95% CI, 1.4−2.7). Inactive cats were more often overweight than 
cats with a normal activity level (OR 1.9; 95% CI, 1.5−2.5). 
4.3 The metabolic profile of Burmese cats (paper IV) 
There were several differences discovered in the metabolic profiles between the 
three cat breeds included in the study; the Burmese, Birman, and MCO. Data from 
the multivariate model revealed that 22 of the 58 quantified NMR metabolites 
were discriminant between breeds. Two branch-chained amino acids, leucine 
and valine, and one aromatic amino acid, tyrosine, were found to differ between 
breeds. Additionally, the amino acids arginine, asparagine, histidine, lysine, and 
methionine, and the amino acid metabolites 2-oxoisocaproic acid, 3-methyl-2-
oxovaleric acid, and dimethylglycine were found discriminative. The meta-
bolites 2-propanol, acetic acid, acetylcarnitine, carnitine, creatine, creatinine, 
O-phosphocholine, succinic acid, taurine, 2-hydrobutyric acid, and glucose also 
differed between breeds.  After adjusting for potential effects of weight and BCS, 
which differed between the breed groups, breed remained significant for 15 
metabolites (Figure 12). 
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Figure 12. Metabolites that were discriminant between breeds after adjusting for weight and body 
condition. Different letters (a, b) indicate breeds that differ from other breeds at P < 0.05. Concen-
trations are shown as least square means, or geometric means, with 95% confidence intervals. 
MCO, Maine coon.  
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Breed differences were found also in the clinical biochemistry and hormonal 
immunoassay results. Breed (P < 0.0001) and weight (P < 0.0001) had signifi-
cant overall effects in the multivariate model, but not BCS (P = 0.14). A 
significant model could be established for creatinine (P < 0.0001), fructosamine 
(P = 0.004), VLDL-TG (P < 0.0001), HDL-cholesterol (P < 0.0001), insulin 
(P = 0.036), adiponectin (P < 0.0001), and IGF-I (P < 0.0012), but not for ALAT 
(P = 0.11) and FFA (P = 0.17). The breed effects are shown in Figure 13. Apart 
from breed, some parameters were also affected by weight, or BCS. For example, 
overweight cats had 20.3 µmol/L higher average creatinine concentrations than 
normal weight cats. Fructosamine concentrations were affected only by weight, 
with an increase in concentration of 8.1 µmol/L per kg of weight (P = 0.0015). 
Concentrations of VLDL-TG increased with 27% per kg of body weight 
(P < 0.0001). Adiponectin concentrations were lower in Burmese cats than in 
MCO cats (P < 0.0001), and were also lowered by an increasing body weight, 
with −40.3 ng/mL (P = 0.0003) per kg. Weight influenced the IGF-I 
concentrations with a 33% increase per kg of body weight (P < 0.0001). 
 
Figure 13. Serum biochemistry and hormonal concentrations that were discriminant between 
breeds after adjusting for weight and body condition. Different letters (a, b) indicate breeds that 
differ from other breeds at P < 0.05. Concentrations are shown as least square means, or geometric 
means, with 95% confidence intervals. MCO, Maine coon; VLDL, very low-density lipoprotein; 
TG, triglycerides; HDL, high-density lipoprotein; chol, cholesterol; IGF, insulin-like growth factor. 
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The main aims of this thesis were to investigate risk factors, such as demo-
graphic and environmental factors, for DM in cats, and to increase understanding 
of disease pathogenesis. Better knowledge of predisposing factors can help cat 
owners and veterinarians to identify cats at risk of developing DM at an earlier 
stage, thereby increasing the possibilities to apply preventive measures to avoid 
disease occurrence, or delay its progression. 
Although DM in cats was uncommon only a few decades ago, it is now 
recognised as one of the most common feline endocrinopathies. The incidence 
is suspected to increase, similar to what is observed among people. Our results 
indicate that overweight, as has been observed in people, is one of the major risk 
factors for developing feline DM.  
  The cat was probably domesticated around 10,000 years ago, at the time of 
the origin of agriculture and permanent human settlements, which created a new 
environment where both mice (Mus musculus domesticus), and subsequently 
wild cats, could thrive (Driscoll et al., 2009a). It is likely that the domestication 
of cats led to fewer adaptations than in dogs, where several genes involved in 
starch digestion and fat metabolism have shown signals of selection, giving dogs 
a better ability to cope with an increasingly starch-rich diet (Axelsson et al., 
2013). Domestication of dogs was likely driven by artificial selection, with 
deliberate breeding by human intervention, while the domestic cat was a product 
of natural selection, without human intervention. Artificial selection to produce 
modern cat breeds has only occurred during the last 200 years (Driscoll et al., 
2009b).  
With the urbanisation process in the last century, the cat has transformed 
from being an active, outdoor hunter to a sedentary, indoor pet. Domestic cats 
are often fed commercially produced diets, often in excessive amounts and 
consisting of less protein and more carbohydrates than is found in their natural 
diet. Altogether, these changes are hypothesised to play a role in the 
development of feline DM (Slingerland et al., 2009; Zoran & Buffington, 2011).  
5 Discussion 
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5.1 Incidence of diabetes mellitus in Swedish cats (paper 
I) 
We started by investigating the general incidence of DM in a large cohort of 
Swedish cats, to be able to make comparisons between breeds, age groups, and 
sex. We did not identify any increase in incidence over time during the years 
2009 to 2013, but the study period might have been too short to enable us to 
document a potential increase. It is also possible that the suspected increase in 
incidence might have already taken place, and that a plateau now has been 
reached. However, we were able to identify several cat breeds at either an 
increased, or a decreased, risk for DM. The top risk breed identified in this study 
was the Burmese cat, a breed that has been identified previously as a high-risk 
breed for DM (Rand et al., 1997; McCann et al., 2007; Lederer et al., 2009).  
We also identified three previously unreported high-risk breeds for DM (the 
Russian Blue, Norwegian Forest cat, and Abyssinian), as well as breeds with a 
decreased risk of DM (the Bengal, Birman, Persian, Ragdoll, and British 
Shorthair breeds).  
In all breeds analysed except the Burmese, there were more male than female 
cats with DM, similar to previous reports (Panciera et al., 1990; McCann et al., 
2007; Prahl et al., 2007; Lederer et al., 2009). The male predilection for DM can 
be explained in several ways. First, male cats are prone to develop obesity (Lund 
et al., 2005). Secondly, male cats tend to have lower insulin sensitivity than 
female cats (Appleton et al., 2001). The lack of sex predilection in the Burmese 
breed indicates that the pathogenesis of DM might differ from that in other 
breeds, and we therefore decided to study the metabolism in the Burmese breed 
in study IV.  
Neutering is another factor that has been associated with an increased risk of 
both obesity and DM. We were not able to investigate the effect of neutering in 
study I, since there was no reliable information on neutering status available in 
the database. If the tendency to neuter male cats was higher than for female cats, 
this could influence the male predilection found. Therefore, we decided to 
investigate more potential risk factors for DM, such as neutering, in study II. 
Age was associated with DM risk, with a peak incidence in middle-aged cats. 
We speculated if this could be due to a simultaneous increase in the incidence of 
obesity, most often seen in middle-aged cats (Lund et al., 2005). The hypothesis 
that some risk factors identified for DM are also risk factors for overweight and 
obesity, was investigated further in study III. The demographic risk factors age, 
sex and breed investigated in study I are all examples of non-modifiable risk 
factors, i.e. factors that cannot be changed in the individual animal. We also 
examined modifiable risk factors, where owners can make adjustments to 
decrease the risk of future development of DM (study II). 
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5.2 Environmental risk factors for diabetes mellitus 
(paper II) 
Diabetes mellitus develops when the insulin-producing β-cells cannot keep pace 
with the cells’ demand for insulin. For feline DM and human T2DM, this is 
associated with exhaustion of the β-cells in conjunction with insulin resistance 
(Rand, 1999; Chatterjee et al., 2017). Most often, there is more than one factor 
contributing to the insulin resistance. To decrease insulin resistance, one or more 
of these contributors need to be identified and addressed. Knowledge of the 
modifiable risk factors in the individual cat is important. In study II, we 
examined modifiable risk factors for DM in cats, by inviting owners of all 
diabetic cats that participated in study I to complete a web survey. As a control 
group, a larger cohort of non-diabetic cats were selected from the same database, 
matched only on birth year with the diabetic cats to avoid introducing un-
necessary bias due to matching (Rothman, 2012).  
Our results highlight the importance of overweight as a risk factor for DM, in 
concordance with other studies on both cats and people (Scarlett & Donoghue, 
1998; German, 2006; McCann et al., 2007; Chen et al., 2012; Chatterjee et al., 
2017). Since there was an interaction present between BCS and type of diet fed 
to the cats, these two variables needed to be interpreted together. Overweight 
was associated with an increased risk of DM, regardless of type of diet. The effect 
of diet on DM risk was significant only within the group of normal weight cats, 
where cats on a diet consisting predominantly of dry food had a fourfold 
increased risk of DM compared to cats on a wet food diet. There was no 
significant effect of type of diet for the group of overweight cats, possibly 
reflecting the higher impact of the overweight itself rather than the effects of 
diet. This study is, to our knowledge, the first study to report dry food as a 
potential risk factor for DM in cats. In people, availability of sugar is a significant 
statistical determinant of DM prevalence rates worldwide (Basu et al., 2013).  
Cats are obligate carnivores, and their original diet consists of small prey, 
with a naturally low carbohydrate content (Plantinga et al., 2011). Even though 
cats were domesticated around 10,000 years ago, they have not been inten-
tionally bred for form or function, instead selection was often based on simple 
traits such as coat colour or pattern. Unlike the dog, where some breeds are 
thousands of years old, most cat breeds were developed within the past 150 
years, mainly in Europe and in the United States (Lipinski et al., 2008). It is 
unlikely that a selection for breed-specific exterior traits would have resulted in 
major changes in the physiology (Plantinga et al., 2011). Likely, cats have not 
yet adapted metabolically to the modern commercial dry food diets, with its 
often high carbohydrate content, served to many of our cats today. For example, 
cats lack the gene for sweet taste, and subsequently also sweet taste receptors. 
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They also lack salivary amylase, the enzyme that initiates digestion of starch, 
and have low concentrations of intestinal amylase and disaccharidases. In the 
liver, the functioning levels of hepatic glucokinase are minimal. Glucokinase is 
the enzyme that phosphorylates glucose to glucose-6-phosphate for further 
metabolic processing such as glycogen formation. There are also minimal 
functioning concentrations of hepatic glycogen synthetase, the enzyme that 
converts glucose into glycogen, in the feline liver. Finally, cats lack fructokinase 
and thus the ability to metabolise fructose (Zoran, 2010). Altogether, this 
indicates that cats are not adapted to handle carbohydrates to the same extent as 
omnivores, such as dog and man. Cats have a rather limited capacity to 
metabolise sugars, resulting in a slower glucose clearance from blood than dogs 
after ingesting a high-starch or glucose-loaded meal (Kienzle, 1994; Hewson-
Hughes et al., 2011b). It has been suggested that high-carbohydrate diets fed to 
cats might contribute to the development of DM by a gradual exhaustion of the 
β-cells due to the increased insulin production in response to the elevated plasma 
glucose concentrations, and by a direct glucotoxic effect on the pancreas with 
apoptosis of the β-cells (Hewson-Hughes et al., 2011a).  
It is unclear from study II if the association between dry food and DM can be 
separated from dry food as a potential risk factor for obesity, even if the cats in 
which the association was seen were subjectively judged as being normal weight 
by the owners. We decided to analyse data from the non-diabetic cats from this 
study in a new study (study III), where we investigated factors associated with 
overweight, to add information on the relationships between exposure (e.g. diet, 
overweight) and outcome (e.g. overweight, DM). These relationships are 
illustrated with a simple directed acyclic graph (DAG) in Figure 14.  
 
Figure 14. A schematic directed acyclic graph (DAG), used in epidemiology to help adjusting for 
and identifying potential confounders and minimise bias. For feline diabetes mellitus (DM), it is 
not known if type of diet has a direct effect on DM risk, or if it is mediated by an increased risk of 
obesity, or both.   
The DAG approach can be used to help identify covariates which should be 
included in the statistical approach to adjust for confounders and minimise bias 
(Shrier & Platt, 2008).  
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Being considered a greedy eater was associated with an increased risk of DM. 
This is another example of a variable that also could be affecting DM risk via an 
increased risk for overweight, or by affecting both DM and overweight risks. The 
potential effect from eating behaviour on body condition is addressed in study 
III. 
Finally, we found that indoor cats more often developed DM than outdoor 
cats. Again, there was an interaction present between indoor confinement and 
access to the outdoors with the cats’ reported activity level. Indoor confinement 
was a risk factor for DM compared to being allowed outdoor access for all cats 
except those reported to be very active by their owners, where no differences 
could be seen. The protective effect from being an outdoor cat is likely mediated 
via a higher amount of exercise compared to indoor cats, but other factors, such 
as an opportunity to hunt, are also plausible as explanations for this finding. A 
lack of activity and exercise have been associated with an increased risk of feline 
DM and T2DM in people (McCann et al., 2007; Slingerland et al., 2009; 
Chatterjee et al., 2017), while physical activity of moderate intensity, such as 
regular walking, has been shown to reduce the risk of T2DM in people (Jeon et 
al., 2007).   
5.3 Prevalence and factors associated with overweight in 
cats (paper III) 
Since overweight is an important risk factor for feline DM, we wanted to 
investigate if the risk factors we identified for DM in study I and II would also 
be associated with overweight. For example, we wanted to investigate if the 
breed predisposition found to DM could be due to a propensity for overweight in 
these breeds. We used cats from two cohorts for study III, the first set of data 
consisted of medical records obtained from cats visiting the University Animal 
Hospital, and the second data set consisted of questionnaire data from the non-
diabetic control group used in study II. The two groups are not directly com-
parable due to differences in the study populations. In the medical records group, 
the BCS was assessed by a veterinarian or veterinary student, whereas in the 
questionnaire group, the owners themselves judged their pet’s BCS. Owners are 
known to underestimate their pet’s body condition, and our belief is that this was 
reflected in the lower prevalence of overweight found in this group (22%), as 
compared to the medical records group (45%). A high prevalence of overweight 
among domestic cats, as in the medical records cohorts in the present study, has 
been reported previously (Sloth, 1992; Scarlett et al., 1994; Colliard et al., 2009; 
Courcier et al., 2010; Cave et al., 2012; Vandendriessche et al., 2017).  
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Another complicating factor is the possibility that the increasing occurrence 
of overweight and obesity in both animals and people, can affect and alter our 
opinion of what is in fact a normal body condition. An association between 
overweight and a diagnosis of DM was observed in cats from the medical records 
cohort. This finding is similar to results presented in previous reports (Scarlett 
& Donoghue, 1998; German, 2006), and results from study II. 
In cross-sectional studies, like the present, it is not possible to determine 
causality, as all variables are estimated at the same point of time. Therefore, only 
associations can be evaluated. Another drawback is the potential problems with 
recall bias, for data drawn from the questionnaire, and selection bias, for the 
medical records data. Finally, estimating a pet’s body condition is a subjective 
measurement, with a potential for inter-observer variability, and also a risk that 
uneducated owners are unable to correctly asses their pets’ BCS.  
We were unable to distinguish any cat breed as predisposed to overweight. 
However, the Birman and Persian cat breeds had a decreased risk of being 
overweight. Based on analyses presented in paper I, these two breeds were also 
identified as low-risk breeds for DM. When comparing all domestic cats with all 
purebreds, the domestic cats were more prone to overweight than the purebreds, 
similar to previous findings (Lund et al., 2005; Colliard et al., 2009; Teng et al., 
2017). Interestingly, the domestic cats were also at a higher risk for DM when 
compared with all purebred cats, as shown in study I.  
Type of diet was associated with risk of overweight, with cats eating pre-
dominantly dry food more often being overweight than cats eating predomi-
nantly wet food. The study population in the questionnaire cohort consisted of 
mainly adult, neutered cats, and conclusions should not be drawn for cats outside 
these criteria. However, studies on younger cats have shown similar results, with 
feeding a dry food diet as a risk factor for overweight (Rowe et al., 2015; Rowe 
et al., 2017). Dry food is typically more energy dense than wet food, which can 
help explain these findings (Zoran, 2002). The nutritional content in the food 
given to cats in this study is unknown, but in general, there is a higher 
carbohydrate content in dry food than in wet food (Villaverde & Fascetti, 2014). 
The higher water content in wet food has also been shown to decrease energy 
intake and body weight in cats (Wei et al., 2011). Cats eat approximately the 
same amount of food (g/kg body weight) irrespective of which diet they are 
given (Morris et al., 2006), which will result in a higher energy intake if the diet 
is more energy dense, as most often is the case for dry food. 
Moreover, feeding cats one of two diets with the same amount of calories, 
but different protein and carbohydrate content, led to weight loss for cats fed the 
high-protein, low-carbohydrate diet, as compared to the low-protein, high-
carbohydrate version (Hill et al., 2015). High-carbohydrate diets resulted in 
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higher postprandial glucose and insulin concentrations, and the duration of 
postprandial glycaemia in cats was markedly longer compared with durations 
observed in dogs and humans (Coradini et al., 2011; Farrow et al., 2012). This 
is likely a reflection of the cat’s strict carnivorous nature, and cats do not appear 
to have any dietary requirements for carbohydrates (Macdonald et al., 1984). 
Cats have as previously discussed very low hepatic glucokinase activity, which 
partly explains the cat’s lower ability to handle glucose. Glycaemia increases 
pancreatic β-cell insulin production. Insulin is an anabolic hormone that 
promotes uptake of glucose from the blood into fat, liver and skeletal muscle 
tissues, where the glucose is converted into either glycogen in skeletal muscle, 
or stored as fat in adipose tissue, or both in the liver. In people, consumption of 
sugar (as in sugar-sweetened beverages) can lead to weight gain and increase the 
risk of obesity, and also increase the risk of developing T2DM (Malik et al., 2006; 
Hu & Malik, 2010; Malik et al., 2010; Hu, 2013).  
It is estimated in people that approximately 30% to 40% of the variance in 
BMI can be attributed to genetics, and 60% to 70% to the environment (Pi-
Sunyer, 2002). If the situation for cats is similar is unknown, but modifiable 
factors such as diet and exercise are likely of high importance also for cats.  
5.4 The metabolic profile of Burmese cats (paper IV) 
The metabolic profile of the Burmese breed was examined, and compared to that 
of the Birman and MCO breeds, using NMR spectroscopy, routine serum 
biochemistry, and hormone immunoassays. Metabolomics is a powerful tool for 
investigating metabolites in biological samples. From obtained data it is possible 
to draw conclusions regarding the individual’s metabolism status and potential 
alterations from normal levels. Significant breed differences were observed from 
the NMR data, serum biochemistry and hormonal assays.   
The pattern of metabolites in the Burmese breed resembled that encountered 
in people with insulin resistance. For example, Burmese cats had higher concen-
trations of 2-hydrobutyric acid and tyrosine, and lower concentrations of 
dimethylglycine (Gall et al., 2010; Stančáková et al., 2012; Magnusson et al., 
2015). 2-Hydroxybutyric acid has been suggested useful as an early indicator of 
insulin resistance in non-diabetic people, and elevated serum concentrations also 
predicted a worsening of glucose tolerance (Gall et al., 2010; Ferrannini et al., 
2013). Increased tyrosine concentrations predicted future T2DM in people in 
another study (Stančáková et al., 2012). It is unknown if the Burmese cats in our 
study were in fact insulin resistant or not, since we did not include any 
interventions to assess insulin sensitivity in the study protocol.   
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Concentrations of 2-oxoisocaproic acid were also higher in Burmese cats 
compared to MCO cats. 2-Oxoisocaproic acid, or alpha-ketoisocaproic acid, is an 
intermediate in the metabolism of leucine, a branch-chained amino acid 
associated with insulin resistance and T2DM in people according to several 
studies (Shaham et al., 2008; Wang et al., 2011; Menni et al., 2013; Guasch-
Ferré et al., 2016). High concentrations of 2-oxoisocaproic acid have been 
shown to induce insulin secretion in rat islets, and stimulation of insulin 
secretion could with time promote DM development via exhaustion of the β-cells 
(Gao et al., 2003; Wang et al., 2011). The Burmese cats also had higher 
concentrations of insulin than the other breeds, although the difference was 
significant only compared with the MCO. Moreover, Burmese cats had lower 
adiponectin concentrations than the MCO breed. Adiponectin is an adipocyte-
derived hormone, an adipokine, with an inverse correlation with obesity in both 
cats and people (Hoenig et al., 2007; Ishioka et al., 2009; Muranaka et al., 2011; 
Tvarijonaviciute et al., 2012; Okada et al., 2017), although conflicting results 
exist in cats (Bjornvad et al., 2014; Witzel et al., 2015). In people, adiponectin 
regulates glucose metabolism by stimulating FFA oxidation, glucose uptake and 
reducing gluconeogenesis, thereby increasing insulin sensitivity (Yamauchi et 
al., 2002; Kadowaki et al., 2006; Gao et al., 2013). Adiponectin has been 
suggested to play a role in explaining why some species, like cats and people, 
develop T2DM in association with obesity, whereas others, such as dogs and 
horses, do not (Verkest & Bjornvad, 2012). 
The Burmese cats included in our study had metabolic patterns compatible 
with insulin resistance patterns in people, however, we did not assess insulin 
sensitivity directly in these cats. Further studies investigating the predisposition 
of Burmese cats to DM is warranted. We did not detect any breed differences in 
the concentrations of FFA, which was somewhat unexpected, since it is the 
increased availability of FFA in people with hypertriglyceridemia due to obesity 
or T2DM that leads to the deleterious effects on insulin uptake by the liver. The 
increased hepatic gluconeogenesis and glucose release that occurs creates a 
vicious circle of hyperglycaemia, further augmenting the insulin resistance 
(Kopelman, 2000; Subramanian & Chait, 2012). Hypertriglyceridemia alone has 
been suggested, in some studies, to cause insulin resistance even without 
concomitant obesity or T2DM (Steiner & Vranic, 1982). Beta-oxidation of FFA 
causes increased intracellular content of metabolites which may interfere with 
insulin-receptor signalling, thereby contributing to the insulin resistance found 
in tissue (Kahn et al., 2006). There is a theory that the dyslipidaemia in Burmese 
cats could be caused by a deficient lipoprotein lipase (LPL), the enzyme 
responsible for hydrolysing TG into FFA for subsequent adipose and skeletal 
muscle tissue utilisation. A deficient LPL would likely have led to a decreased, 
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rather than increased, β-oxidation. Abnormalities in LPL function have also been 
associated with insulin resistance and T2DM in people (Mingrone et al., 1999; 
Mead et al., 2002). To measure LPL concentrations it is necessary to administer 
heparin intravenously to release the enzyme into the circulation (Jeppesen et al., 
1995), and therefore assessment of LPL activity was not performed in our study.  
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The hypothesis underlying this thesis was that the change in lifestyle of domestic 
cats, which has occurred during the last century, would be associated with both 
obesity and DM.  
 
In this thesis, we have shown that: 
 
 The general incidence of DM in insured, Swedish cats was 11.6 cases per 
10,000 CYAR. 
 Several cat breeds displayed an increased risk of developing DM, with the 
Burmese breed at a fivefold risk (IRR 5.2; 95% CI, 3.6−7.6) compared to other 
purebred cats.  
 Middle-aged, male cats were at increased risk of both overweight and DM. 
 Indoor confinement and inactivity were associated with an increased risk of 
DM, and overweight, respectively. 
 Being fed predominantly dry food was associated with an increased risk of 
being overweight. In normal-weight cats, there was an association between 
eating predominantly dry food and an increased risk of DM.  
 Cats visiting an animal hospital had a high prevalence of overweight (45%). 
 For cats scored by their owners, one out of five cats (22%) was considered 
overweight. 
 The metabolic profile of Burmese cats resembled that of people with insulin 
resistance. 
 
Since obesity is an important risk factor for DM in cats and T2DM in people, we 
studied factors associated with both overweight and DM in this thesis. Cats from 
several breeds displayed an increased risk of developing DM, with the Burmese 
breed as the most predisposed with a fivefold increased risk compared to other 
purebred cats. We were not able to detect any breed associated with overweight, 
but on the other hand, the Birman and Persian cat breeds had lower risk for 
overweight than other breeds, and also a decreased risk for DM.  
6 Conclusions and future remarks 
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Age, breed and sex are examples of non-modifiable risk factors, important to 
recognise, but obviously unfeasible to adjust in the individual animal. 
Modifiable risk factors, on the other hand, are possible for the veterinarian and 
cat owner to address. We confirmed that overweight is an important risk factor 
for feline DM. The prevalence of overweight varied between groups of cats. Cats 
visiting an animal hospital were scored by either a veterinarian or a veterinary 
student, and showed a high prevalence of overweight with almost every other 
cat considered overweight. In contrast, for cats scored by their owners, one out 
of five cats was considered overweight. We believe that this discrepancy is 
mainly due to an inability of cat owners to truly apprehend a problem with over-
weight in their pets. When increasing numbers of pets and people become 
overweight or obese, there is a risk that our perception of what is actually normal 
is altered. Therefore, it is important for veterinarians to assess the BCS in all pets 
to make owners aware of their pet’s current and ideal body condition, and to 
address deviances properly. 
A new finding was the association between feeding predominantly dry food, 
and an increased risk of DM in middle-aged, neutered cats, judged as being 
normal weight by their owners. We also detected an association between eating 
mainly dry food and being overweight. Cats are obligate carnivores, adapted for 
hunting, and eating, small prey. During the last decades, there has been a change 
in the cats’ diet, with the introduction of commercial pet foods, often with a 
higher carbohydrate content in comparison with the cats’ natural diet. Simul-
taneously, there has been a shift from a predominantly outdoor environment for 
domesticated cats to an indoor lifestyle, with a decreased physical activity, 
because cats no longer need to hunt to obtain food (Verbrugghe et al., 2012). 
The possible association between dry food and both overweight and DM as 
indicated by our studies, warrants further attention, since dry food is fed to a vast 
number of cats all over the world. 
In people, despite the fact that genetic association studies so far have 
identified more than 100 gene loci influencing the risk of T2DM, these only have 
small to moderate effects on the individual’s susceptibility to the disease 
(Gaulton, 2017). In cats, the genetic predisposition to DM is mainly unknown, 
however, the breed predisposition seen is an indicator of a genetic influence. 
Therefore, other factors influencing the DM risk are important to acknowledge. 
Demographic factors such as age, breed, and sex, are non-modifiable, but 
knowledge of both modifiable and non-modifiable risk factors is important. It is 
the sum of all factors contributing to insulin resistance that in susceptible 
individuals, will contribute to the development of disease. In people, most of the 
identified genetic risk loci are associated with β-cell function. It is not unlikely 
that the same is true for cats. Further studies are needed to investigate the β-cell 
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function in cats with or without DM, for example using gene expression studies. 
For individuals with an increased susceptibility to DM and T2DM, it is important 
to recognise all potential risk factors, and to address the modifiable factors to 
possibly avoid disease development. We have shown that overweight, a lack of 
exercise, and possibly dry food, are examples of modifiable risk factors for DM 
in cats.  
Finally, we investigated the predisposition of Burmese cats to develop DM by 
characterising their metabolic profile and compare it with that of two other cat 
breeds, of low or medium risk of DM. Results from NMR spectroscopy, serum 
biochemistry and hormone immunoassays showed a metabolic profile of the 
Burmese cats resembling that of people with insulin resistance. Differing 
concentrations of several NMR metabolites, as well as increased concentrations 
of insulin, and lower concentrations of adiponectin, were found in the Burmese 
cats compared to other breeds. Further investigations are necessary to elucidate 
the factors and mechanisms underlying the predisposition of Burmese cats to 
develop DM.   
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Diabetes mellitus (DM) in cats is similar to type 2 diabetes in people. Cats and 
humans share many risk factors for the disease, such as obesity and a sedentary 
lifestyle. In people, ethnicity has been associated with an increased risk of DM. 
In cats, a breed predisposition has been described, with the Burmese breed at 
increased risk. The main aim of this thesis was to investigate risk factors for DM 
in cats.  
We used records from a pet insurance company to investigate how common 
the disease is in Swedish cats. We also investigated if the risk of DM varies with 
age, sex and breed of the cats. The highest risk of DM was seen in 13-year old 
cats. Male cats developed DM twice as often as female cats. The Burmese breed, 
along with the Russian Blue, Abyssinian, and Norwegian Forest cat breeds, had 
an increased risk of DM, while cats from several other breeds had a lower risk.  
We invited owners of diabetic and non-diabetic cats, insured by the same 
insurance company, to participate in a web survey. The survey contained 
questions on e.g. body condition, eating behaviour, activity levels, type of diet, 
and if the cat was an indoor or outdoor cat. We found that overweight cats had 
an increased risk of developing DM. Cats described as being greedy eaters by 
their owners also had a higher risk of developing disease. On the other hand, 
access to the outdoors was protective against DM. In normal weight cats, there 
was an increased risk of DM in cats eating mostly dry food, compared to wet 
food.  
Since overweight turned out to be a strong risk factor for DM, we decided to 
study factors associated with overweight. We found several risk factors that were 
similar for both DM and overweight, such as eating mainly dry food, being male, 
middle-aged, and considered a greedy eater. Birman and Persian breeds, with a 
decreased risk of DM, were less often overweight.  
Finally, we studied the metabolism in cats of the Burmese breed. There were 
differences in the metabolic profiles between the Burmese, Birman, and Maine 
coon cat breeds, with a pattern in the Burmese cats resembling people with 
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insulin resistance. Insulin resistance is a condition usually seen in people before 
type 2 diabetes develops. 
In conclusion, both new and previously reported factors associated with DM 
in cats were identified. The Burmese breed predisposition was verified, and three 
new breeds with an increased risk of DM were identified. We could confirm that 
overweight is an important risk factor for DM in cats. Being a middle-aged, male, 
inactive cat increased the risk of both overweight and DM. Knowledge of 
predisposing factors can help owners and veterinarians to identify cats at risk, 
enabling a possibility to prevent disease or delay its development.  
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Diabetes mellitus (DM) hos katt liknar människans typ 2-diabetes. Katter och 
människor delar flera riskfaktorer för sjukdomen, såsom övervikt och en 
stillasittande livsstil. Hos människor har etnicitet visat sig ha ett samband med 
risken för DM. Hos katt har vissa raser, som t.ex. burma, en ökad risk för DM. 
Det huvudsakliga syftet med denna avhandling har varit att undersöka 
riskfaktorer för DM hos katter.  
Vi använde statistik från ett djurförsäkringsbolag för att undersöka hur vanlig 
sjukdomen är hos våra svenska katter. Vi undersökte också om risken för DM 
varierade med katternas ålder, kön och ras. Störst risk för DM sågs hos katter vid 
13 års ålder. Hankatter utvecklade DM dubbelt så ofta som honkatter. Katter av 
raserna burma, russian blue, abessinier och norsk skogkatt hade en ökad risk för 
DM, medan flera andra raser hade en minskad risk.   
Vi bjöd in ägare till katter med och utan DM, försäkrade i samma försäkrings-
bolag, att delta i en enkätundersökning. Enkäten innehöll frågor om t.ex. kattens 
hull, ätbeteende, aktivitetsnivå, om katten var inne- eller utekatt, och typ av foder 
som katten åt. Vi fann att överviktiga katter hade en klart förhöjd risk att drabbas 
av DM. Katter som beskrevs av sina ägare som glupska hade också en förhöjd 
risk för sjukdomen. Att vara utekatt var däremot skyddande mot DM. I gruppen 
normalviktiga katter hade katter som åt mestadels torrfoder en ökad risk för DM 
jämfört med katter som åt mest blötmat.   
Eftersom övervikt visade sig vara en så stark riskfaktor för DM, studerade vi 
vilka faktorer som hade ett samband med övervikt. Vi fann flera faktorer som 
var desamma för både DM och övervikt, som t.ex. att vara hankatt, medelålders, 
glupsk, och att äta mestadels torrfoder. Katter av raserna birma och perser hade 
en lägre risk för DM, och var också mer sällan överviktiga.  
Slutligen undersökte vi ämnesomsättningen hos katter av rasen burma 
jämfört med katter av raserna birma och maine coon. Vi såg skillnader i ämnes-
omsättningen mellan raserna, med ett mönster hos burmorna som liknar det som 
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ses hos människor med insulinresistens. Insulinresistens är ett tillstånd som 
vanligtvis ses hos människor innan typ 2-diabetes utvecklas. 
Sammanfattningsvis har vi identifierat både nya och tidigare rapporterade 
faktorer som har ett samband med DM hos katt. Vi kunde bekräfta att rasen burma 
är predisponerad för DM, och vi identifierade tre nya raser med en ökad risk för 
DM. Att vara en medelålders, inaktiv hankatt ökade risken för både övervikt och 
DM. Kunskap om vilka faktorer som bidrar till att öka risken för DM är viktiga 
att känna till, för att tidigare kunna hitta de katter som har en förhöjd risk, och 
därmed ge veterinärer och kattägare en möjlighet att förebygga sjukdomen eller 
fördröja sjukdomsdebuten.  
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